#USA #New York #Investor Rights #Halper Sadeh #INZY

Halper Sadeh LLC Investigates INZY, SVT, HLGN for Shareholders

Halper Sadeh LLC, an esteemed law firm dedicated to protecting the rights of investors, has recently announced an investigation into three companies: Inozyme Pharma, Inc. (NASDAQ: INZY), Servotronics, Inc. (NYSE: SVT), and Heliogen, Inc. (OTCQX: HLGN). The inquiry aims to uncover possible infractions of federal securities laws and breaches of fiduciary duties owed to shareholders in connection with proposed transactions involving these companies.

Inozyme Pharma, Inc. (INZY)

Inozyme Pharma has attracted the attention of Halper Sadeh LLC due to its planned sale to BioMarin Pharmaceutical Inc. The transaction values Inozyme shares at $4.00 each. Given the proposed sale price, concerns have arisen regarding whether shareholders are receiving adequate compensation for their investments. If you hold shares in Inozyme Pharma, it is crucial to understand your rights and options in this impending sale. Halper Sadeh LLC invites shareholders of INZY to contact them for a free consultation to explore potential actions that could enhance shareholder value.

Servotronics, Inc. (SVT)

Similarly, Servotronics is under scrutiny following its agreement to sell to TransDigm Group Incorporated for $38.50 per share in cash. This value has raised questions about whether shareholders are being offered a fair deal in light of the company's financial health and market position. Halper Sadeh LLC encourages shareholders of Servotronics to reach out and discuss their legal rights in the context of this transaction.

Heliogen, Inc. (HLGN)

Heliogen's proposed sale to Zeo Energy Corp. is also being examined by Halper Sadeh LLC. Under the current terms, upon the completion of this transaction, Heliogen’s securityholders will receive shares of Zeo’s Class A common stock, which is estimated to be worth around $10 million collectively. The actual payout for Heliogen shareholders will depend on the company's net cash position at the time of closing, necessitating vigilance to ensure shareholder interests are fully represented. Shareholders are strongly advised to contact Halper Sadeh LLC to learn more about how they may protect their investments.

A Call to Action for Shareholders

Halper Sadeh LLC has a reputation for driving corporate reforms and recovering significant financial losses for investors impacted by fraud and corporate mismanagement. The firm is passionate about advocating for shareholder rights and might seek increased compensation, additional disclosures, or other legal reliefs on behalf of investors in these distressed cases.

The inquiry will be undertaken on a contingency fee basis, which means that shareholders will not be subjected to upfront legal costs. Instead, Halper Sadeh LLC absorbs any initial legal expenses, only charging fees based on successful outcomes.

Shareholders of INZY, SVT, and HLGN are encouraged to engage with Halper Sadeh LLC without any obligation to better understand their legal choices and options. To discuss your situation, please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email them at [email protected] or [email protected]. This is a crucial opportunity for investors to ensure their rights are safeguarded during these corporate transitions. Investor protection remains a top priority in an environment where securities fraud and corporate misconduct can significantly affect shareholder interests.

In closing, the Halper Sadeh investigation stands as a reminder to shareholders about the importance of transparency and due diligence in corporate dealings. It serves to uphold corporate accountability to ensure investors are not left indifferent during significant business transactions.